Clinical Trial Update: Effect of Botulinum Toxin in Neurogenic Bladders in Children With Myelomeningocele [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating botulinum toxin for neurogenic bladder in children with myelomeningocele.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelomeningocele
• Neurogenic Bladder

Drugs mentioned

• OnabotulinumtoxinA (botulinum toxin type A)

Snippet

Sponsor: University of Aarhus | Conditions: Myelomeningocele, Bladder, Neurogenic | Phase 4 | Status: UNKNOWN